Clinical Trial Update: A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating potential drug interactions between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in patients with advanced solid tumors has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• DIGOXIN (Digoxin)
• Repotrectinib (repotrectinib)
• Rosuvastatin (rosuvastatin)
• metformin (metformin)

Snippet

Sponsor: Turning Point Therapeutics, Inc. | Conditions: Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | Status: WITHDRAWN